ArticleTrials2018

Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.

Dinesh Selvarajah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.